Treatment Duration of Each Anti-COVID-19 Agent Used in a Tertiary Hospital in Japan
Masafumi Seki, Kazunori Enami · 2025
Read Treatment Duration of Each Anti-COVID-19 Agent Used in a Tertiary Hospital in Japan by Masafumi Seki, Kazunori Enami (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12850542.txt.
Description
Masafumi Seki and Kazunori Enami compare how long four COVID-19 drugs were given at a large hospital in Japan, in a 2025 study. All four drugs are approved there for adults. The team tracked 114 patients treated on admission and watched virus levels fall.
Virus antigen dropped enough in every case, so all four drugs worked in practice. Course length still differed by drug: the shortest ran about 4.1 days on average, and the longest about 5.1 days. The authors read the gap as a hint that the drugs' real world strength differs, even when each clears the virus. Ward level data like this can guide stock and cost choices.
Catalog record
| CREATOR | Masafumi Seki, Kazunori Enami |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |